Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 12/20 | 0.55 |
| ▸ | PPARA | Q07869 | 8/20 | 0.51 |
| ▸ | PPARD | Q03181 | 6/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4097793 | 0.89 | PPARG (0.64) | PPARGPPARAPPARDNPC1 | |
| SCHEMBL4092953 | 0.89 | PPARG (0.59) | PPARGPPARAPPARDNPC1 | |
| SCHEMBL4099824 | 0.87 | PPARG (0.61) | PPARGPPARAPPARD | |
| SCHEMBL4097658 | 0.87 | PPARA (0.59) | PPARGPPARAPPARDNPC1 | |
| Trifluoroacetic Acid SCHEMBL4098182 | 0.86 | PPARG (0.41) | PPARGPPARAPPARDNPC1SMN1; SMN2 | |
| SCHEMBL4107824 | 0.85 | NPC1 (0.58) | PPARGPPARAPPARDNPC1HTT | |
| SCHEMBL4091511 | 0.85 | PPARG (0.51) | PPARGPPARAPPARDNPC1LMNA | |
| SCHEMBL4097609 | 0.83 | NPC1 (0.52) | PPARGPPARAPPARDNPC1SMN1; SMN2 | |
| SCHEMBL4107394 | 0.81 | PPARG (0.63) | PPARGPPARAPPARDNPC1HTT | |
| SCHEMBL4106819 | 0.80 | PPARG (0.47) | PPARGPPARAPPARDNPC1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090054435-A1 | Phenoxyalkanoic Acid Compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1911738-A1 | PHENOXYALKANOIC ACID COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2008-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054435-A1 | Phenoxyalkanoic Acid Compound | PNLIP, GPR119, LIPC | PPARG 23/4885PPARA 8/4885PPARD 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.